Retrospective Study
Copyright ©The Author(s) 2022.
World J Gastroenterol. Nov 21, 2022; 28(43): 6157-6167
Published online Nov 21, 2022. doi: 10.3748/wjg.v28.i43.6157
Table 1 Demography, celiac disease serology, and endoscopic findings by cohorts and the overall population
Demographic data and upper GI endoscopic findings
Naples/Salerno cohort
Buenos Aires cohort
Hamilton cohort
Padua cohort
Overall CeD population
Total population930 (70.0)97 (7.3)167 (12.6)134 (10.1)1328
Age in yr34 (26-42)35 (27-44)39 (27-54)35 (23-46)35 (26-43)
Female sex754 (81.1)88 (90.7)122 (73.0)100 (74.6)1064 (80.1)
Patients with positive serology899 (96.7)97 (100)147 (88.0)130 (97.0)1269 (95.6)
Patients with at least one significant endoscopic abnormality89 (9.6)8 (8.2)34 (20.4)4 (3.0)135 (10.2)
Reflux esophagitis with erosions78 (8.4)1 (1.0)6 (3.6)085 (6.4)
Esophageal peptic ulcers001 (0.6)01 (0.2)
Esophageal malignancy00000
Suspicion of esophageal metaplasia3 (0.3)013 (7.8)016 (1.2)
Biopsy confirmed Barrett’s esophagus2 (0.2)01(0.6)03 (0.2)
Gastric erosions07 (7.2)16 (9.6)4 (3.0)27 (2.0)
Gastric ulcers1 (0.1)0001 (0.1)
Gastric cancer00000
Duodenal erosions0015 (9.0)015 (1.1)
Duodenal ulcers8 (0.9)1 (1.0)6 (3.6)015 (1.1)
Duodenal cancer00000